...
首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >The impact of surgical sperm retrieval on the in vitro fertilization outcomes of infertile patients with temporary ejaculation failure on their oocyte retrieval day
【24h】

The impact of surgical sperm retrieval on the in vitro fertilization outcomes of infertile patients with temporary ejaculation failure on their oocyte retrieval day

机译:手术精子回收对不育不育患者临时射精失败的卵子取出日体外受精结果的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the impact of testicular sperm aspiration on the clinical outcomes of IVF patients with temporary ejaculation failure (TEF) on the day of oocyte retrieval. Design: A case-control study. Setting: University-Affiliated IVF center. Patient(s): One hundred eight infertile couples encountering TEF on the day of oocyte retrieval. Intervention(s): Testicular sperm aspiration and intracytoplasmic sperm injection (TESA-ICSI) were employed to help the TEF couples to complete their IVF treatments. A group of obstructive azoospermia (OA) patients was chosen as a control group to evaluate the efficiency and safety of this intervention. Main Outcome Measure(s): Fertilization rates, transferable embryo rates, and clinical pregnancy rates (PRs). Result(s): Through the TESA-ICSI, TEF couples achieved a 38.83% (40/103) clinical PR per IVF cycle. Compared with the OA group, the TEF group showed a comparable fertilization rate (66.43% vs. 65.25%), transferable embryo rate (60.76% vs. 60.85%), and PR (51.61% vs. 50.00%) in thawed ET cycles but a relatively low PR (25.49% vs. 44.64%) in fresh ET cycles. Conclusion(s): TESA-ICSI is a relatively efficient and safe way to help the patients encountering TEF.
机译:目的:评估在取卵当天,睾丸精子抽吸对IVF临时射精失败(TEF)患者的临床结局的影响。设计:病例对照研究。地点:大学附属试管婴儿中心。患者:卵母细胞取回当天有108例不育夫妇遇到TEF。干预:睾丸精子抽吸术和胞浆内精子注射(TESA-ICSI)被用来帮助TEF夫妇完成其IVF治疗。选择一组阻塞性无精子症(OA)患者作为对照组,以评估这种干预的效率和安全性。主要观察指标:受精率,可移植胚胎率和临床妊娠率(PRs)。结果:通过TESA-ICSI,TEF夫妇在每个IVF周期中达到了38.83%(40/103)的临床PR。与OA组相比,TEF组在融化的ET周期中显示出相当的受精率(66.43%vs. 65.25%),可移植胚胎发生率(60.76%vs. 60.85%)和PR(51.61%vs. 50.00%),但在新的ET周期中PR相对较低(25.49%对44.64%)。结论:TESA-ICSI是一种相对有效和安全的方法,可以帮助遇到TEF的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号